secwatch.observer — SEC 8-K summary
======================================

Issuer:     Context Therapeutics Inc. (CNTX)
CIK:        0001842952
Form:       8-K
Filed at:   2026-03-13T23:59:59+00:00
Accession:  0001628280-26-017691
Event type: litigation
Sentiment:  neutral
Materiality: 0.60
Item codes: 5.03, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Context Therapeutics removes classified board and for-cause removal after court-approved settlement
--------------------------------------------------------------------------------

- Court approved stipulation invalidating 3-year director terms and for-cause removal provisions from charter.
- Certificate of Correction filed with Delaware Secretary of State on March 11, 2026.
- Directors' terms expire at 2026 annual meeting; directors can be removed with or without cause by majority vote.
- Stockholder class action dismissed with prejudice as to plaintiff; court retains jurisdiction over mootness fee.
- 2026 annual meeting set for June 24, 2026; record date April 27, 2026; nominees will serve one-year terms.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1842952/000162828026017691/0001628280-26-017691-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1842952/000162828026017691/cntx-20260311.htm
  HTML page:      https://secwatch.observer/filing/0001628280-26-017691

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer